Stratum corneum defensive functions: An integrated view

Journal of Investigative Dermatology

Volumn 125, Issue 2, 2005, Pages 183-200

  Elias, Peter M ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Barrier function; Corneodesmosomes; Cytokines; Desquamation; Hydration; Lamellar bodies; Lamellar body; pH; Psychological stress; Stratum corneum

Indexed keywords

CATHEPSIN G; CYSTEINE PROTEINASE; CYTOKINE; GROWTH FACTOR; PROTEINASE INHIBITOR; SERINE PROTEINASE; LIPID;

CALCIUM SIGNALING; CELLULAR DISTRIBUTION; CYTOSOL; DEFENSE MECHANISM; DESQUAMATION; GRANULAR CELL; HOMEOSTASIS; HUMAN; LAMELLAR BODY; LIPOGENESIS; MEMBRANE FORMATION; NONHUMAN; PERMEABILITY BARRIER; PH; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION; STRATUM CORNEUM; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; EPIDERMIS; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; EPIDERMIS; HUMANS; LIPIDS; SIGNAL TRANSDUCTION;

EID: 24344448276     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23668.x     Document Type: Review

References (242)

1. Alkemade JA, Molhuizen HO, Ponec M, et al: SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci 107 (Part 8):2335-2342, 1994
2. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD: Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 117:309-317, 2001
3. Aly R, Shirley C, Cunico B, Maibach HI: Effect of prolonged occlusion on the microbial flora, pH, carbon dioxide and transepidermal water loss on human skin. J Invest Dermatol 71:378-381, 1978
4. Beare JM, Cheeseman EA, Gailey AA, Neill DW: The pH of the skin surface of children with seborrhoeic dermatitis compared with unaffected children. Br J Dermatol 70:233-241, 1958
5. Behne M, Elias PM, Mauro T: The antiporter NHE1 influences the function of the SC pH gradient. J Skin Barrier Res 3:3-10, 2001
6. Behne M, Uchida Y, Seki T, de Montellano PO, Elias PM, Holleran WM: Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function. J Invest Dermatol 114:185-192, 2000
7. Behne MJ, Barry NP, Hanson KM, et al: Neonatal development of the stratum corneum pH gradient: Localization and mechanisms leading to emergence of optimal barrier function. J Invest Dermatol 120:998-1006, 2003
8. Behne MJ, Meyer JW, Hanson KM, et al: NHE1 regulates the stratum corneum permeability barrier homeostasis. Microenvironment acidification assessed with fluorescence lifetime imaging. J Biol Chem 277:47399-47406, 2002
9. Bernard D, Mehul B, Thomas-Collignon A, Simonetti L, Remy V, Bernard MA, Schmidt R: Analysis of proteins with caseinolytic activity in a human stratum corneum extract revealed a yet unidentified cysteine protease and identified the so-called "stratum corneum thiol protease" as cathepsin L2. J Invest Dermatol 120:592-600, 2003
10. Bibel DJ, Aly R, Shinefield HR: Antimicrobial activity of sphingosines. J Invest Dermatol 98:269-273, 1992
11. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA, Roop DR: Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 104:405-410, 1995
12. Bitoun E, Chavanas S, Irvine AD, et al: Netherton syndrome: Disease expression and spectrum of SPINK5 mutations in 21 families. J Invest Dermatol 118:352-361, 2002
13. Bouwstra JA, de Graaff A, Gooris GS, Nijsse J, Wiechers JW, van Aelst AC: Water distribution and related morphology in human stratum corneum at different hydration levels. J Invest Dermatol 120:750-758, 2003
14. Bouwstra JA, Gooris GS, Dubbelaar FE, Weerheim AM, Ponec M: pH, cholesterol sulfate, and fatty acids affect the stratum corneum lipid organization. J Invest Dermatol Symp Proc 3:69-74, 1998
15. Bouwstra JA, Gooris GS, Dubbelaar FE, Ponec M: Phase behaviour of skin barrier model membranes at pH 7.4. Cell Mol Biol 46:979-992, 2000
16. Braff MH, Di Nardo A, Gallo RL: Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 124:394-400, 2005
17. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W: Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366, 1996
18. Braissant O, Wahli W: Differential expression of peroxisome proliferator-activated receptor-alpha, -beta, and -gamma during rat embryonic development. Endocrinology 139:2748-2754, 1998
19. Brattsand M, Egelrud T: Purification, molecular cloning, and expression of a human stratum corneum trypsin-like serine protease with possible function in desquamation. J Biol Chem 274:30033-30040, 1999
20. Brown MS, Goldstein JL: Sterol regulatory element binding proteins (SREBPs): Controllers of lipid synthesis and cellular uptake. Nutr Rev 56:1-S3, 1998, discussion S54-S75
21. Candi E, Tarcsa E, Digiovanna JJ, Compton JG, Elias PM, Marekov LN, Steinert PM: A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases. Proc Natl Acad Sci USA 95:2067-2072, 1998
22. Caubet C, Jonca N, Brattsand M et al: Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 122:1235-1244, 2004
23. Chakravarty R, Rice RH: Acylation of keratinocyte transglutaminase by palmitic and myristic acids in the membrane anchorage region. J Biol Chem 264:625-629, 1989
24. Chamlin SL, Kao J, Frieden IJ, et al: Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: Changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47:198-208, 2002
25. Chapman SJ, Walsh A, Jackson SM, Friedmann PS: Lipids, proteins and corneocyte adhesion. Arch Dermatol Res 283:167-173, 1991
26. Chavanas S, Bodemer C, Rochat A, et al: Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 25:141-142, 2000
27. Choate KA, Kinsella TM, Williams ML, Nolan GP, Khavari PA: Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum Gene Ther 7:2247-2253, 1996a
28. Choate KA, Medalie DA, Morgan JR, Khavari PA: Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 2:1263-1267, 1996b
29. Choate KA, Williams ML, Elias PM, Khavari PA: Transglutaminase 1 expression in a patient with features of harlequin ichthyosis: Case report. J Am Acad Dermatol 38:325-329, 1998
30. Christophers E, Kligman AM: Visualization of the cell layers of the stratum corneum. J Invest Dermatol 42:407-409, 1964
31. Chujor CS, Feingold KR, Elias PM, Holleran WM: Glucosylceramide synthase activity in murine epidermis: Quantitation, localization, regulation, and requirement for barrier homeostasis. J Lipid Res 39:277-285, 1998
32. Corden LD, McLean WH: Human keratin diseases: Hereditary fragility of specific epithelial tissues. Exp Dermatol 5:297-307, 1996
33. Dale BA, Presland RB, Lewis SP, Underwood RA, Fleckman P: Transient expression of epidermal filaggrin in cultured cells causes collapse of intermediate filament networks with alteration of cell shape and nuclear integrity. J Invest Dermatol 108:179-187, 1997
34. Denda M, Sato J, Masuda Y, et al: Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 111:858-863, 1998
35. Denda M, Tsuchiya T, Elias PM, Feingold KR: Stress alters cutaneous permeability barrier homeostasis. Am J Physiol Regul Integr Comp Physiol 278:367-R372, 2000
36. Denda M, Wood LC, Emami S, Calhoun C, Brown BE, Elias PM, Feingold KR: The epidermal hyperplasia associated with repeated barrier disruption by acetone treatment or tape stripping cannot be attributed to increased water loss. Arch Dermatol Res 288:230-238, 1996
37. De Simone C, Masini C, Cattaruzza MS, Guerriero C, Cerimele D, Norval M: Urocanic acid isomers in patients with non-melanoma skin cancer. Br J Dermatol 144:858-861, 2001
38. Doering T, Holleran WM, Potratz A, Vielhaber G, Elias PM, Suzuki K, Sandhoff K: Sphingolipid activator proteins are required for epidermal permeability barrier formation. J Biol Chem 274:11038-11045, 1999
39. Dunsche A, Acil Y, Dommisch H, Siebert R, Schroder JM, Jepsen S: The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 110:121-124, 2002
40. Duplus E, Forest C: Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 64:893-901, 2002
41. Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the study of gene regulation and cell differentiation. Physiol Rev 77:397-424, 1997
42. Egberts F, Heinrich M, Jensen JM, et al: Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation. J Cell Sci 117: 2295-2307, 2004
43. Ekanayake-Mudiyanselage S, Aschauer H, Schmook FP, Jensen JM, Meingassner JG, Proksch E: Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol 111:517-523, 1998
44. Ekholm IE, Brattsand M, Egelrud T: Stratum corneum tryptic enzyme in normal epidermis: A missing link in the desquamation process? J Invest Dermatol 114:56-63, 2000
45. Elias P, Ahn S, Brown B, Crumrine D, Feingold KR: Origin of the epidermal calcium gradient: Regulation by barrier status and role of active vs passive mechanisms. J Invest Dermatol 119:1269-1274, 2002a
46. Elias PM, Ahn SK, Denda M, et al: Modulations in epidermal calcium regulate the expression of differentiation-specific markers. J Invest Dermatol 119:1128-1136, 2002b
47. Elias PM, Brown BE: The mammalian cutaneous permeability barrier: Defective barrier function is essential fatty acid deficiency correlates with abnormal intercellular lipid deposition. Lab Invest 39:574-583, 1978
48. Elias PM, Brown BE, Ziboh VA: The permeability barrier in essential fatty acid deficiency: Evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol 74:230-233, 1980
49. Elias PM, Crumrine D, Rassner U, et al: Basis for abnormal desquamation and permeability barrier dysfunction in RXLI. J Invest Dermatol 122:314-319, 2004
50. Elias PM, Cullander C, Mauro T, Rassner U, Komuves L, Brown BE, Menon GK: The secretory granular cell: The outermost granular cell as a specialized secretory cell. J Invest Dermatol Symp Proc 3:87-100, 1998a
51. Elias PM, Fartasch M, Crumrine D, Behne M, Uchida Y, Holleran WM: Origin of the corneocyte lipid envelope (CLE): Observations in harlequin ichthyosis and cultured human keratinocytes. J Invest Dermatol 115:765-769, 2000
52. Elias PM, Feingold KR: Lipids and the epidermal water barrier: Metabolism, regulation, and pathophysiology. Semin Dermatol 11:176-182, 1992
53. Elias PM, Feingold KR: Skin as an organ of protection. In: Freedberg I, et al: (ed). Fitzpatrick's Dermatology in General Medicine. Philadelphia: McGraw-Hill, 1999; p 164-174
54. Elias PM, Feingold KR: Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol 137:1079-1081, 2001
55. Elias PM, Feingold KR: Skin as an organ of protection. In: Freedberg I, et al: (ed). Fitzpatrick's Dermatology in General Medicine. Philadelphia: McGraw-Hill, 2003; p 164-174
56. Elias PM, Ghadially R: The aged epidermal permeability barrier: Basis for functional abnormalities. Clin Geriatr Med 18:103-120, 2002
57. Elias PM, Goerke J, Friend DS: Mammalian epidermal barrier layer lipids: Composition and influence on structure. J Invest Dermatol 69:535-546, 1977a
58. Elias PM, McNutt NS, Friend DS: Membrane alterations during cornification of mammalian squamous epithelia: A freeze-fracture, tracer, and thin-section study. Anat Rec 189:577-594, 1977b
59. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26, 1991
60. Elias PM, Menon GK, Grayson S, Brown BE: Membrane structural alterations in murine stratum corneum: Relationship to the localization of polar lipids and phospholipases. J Invest Dermatol 91:3-10, 1988
61. Elias PM, Schmuth M, Uchida Y, et al: Basis for the permeability barrier abnormality in lamellar ichthyosis. Exp Dermatol 11:248-256, 2002c
62. Elias PM, Wood LC, Feingold KR: Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Dermat 10:119-126, 1999
63. Ellis CN, Varani J, Fisher GJ, et al: Troglitazone improves psoriasis and normalizes models of proliferative skin disease: Ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation. Arch Dermatol 136:609-616, 2000
64. Farrell AM, Uchida Y, Nagiec MM, Harris IR, Dickson RC, Elias PM, Holleran WM: UVB irradiation up-regulates serine palmitoyltransferase in cultured human keratinocytes. J Lipid Res 39:2031-2038, 1998
65. Fartasch M, Williams ML, Elias PM: Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: Differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 135:823-832, 1999
66. Feingold KR: The regulation and role of epidermal lipid synthesis. Adv Lipid Res 24:57-82, 1991
67. Feingold KR, Brown BE, Lear SR, Moser AH, Elias PM: Localization of de novo sterologenesis in mammalian skin. J Invest Dermatol 81:365-369, 1983
68. Feingold KR, Man MQ, Menon GK, Cho SS, Brown BE, Elias PM: Cholesterol synthesis is required for cutaneous barrier function in mice. J Clin Invest 86:1738-1745, 1990
69. Feingold KR, Man MQ, Proksch E, Menon GK, Brown BE, Elias PM: The lovastatin-treated rodent: A new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol 96:201-209, 1991
70. Feliciani C, Gupta AK, Sauder DN: Keratinocytes and cytokine/growth factors. Crit Rev Oral Biol Med 7:300-318, 1996
71. Finlay-Jones JJ, Hart PH: Photoprotection: Sunscreens and the immunomodulatory effects of UV irradiation. Mutat Res 422:155-159, 1998
72. Fitzgerald ML, Moore KJ, Freeman MW: Nuclear hormone receptors and cholesterol trafficking: The orphans find a new home. J Mol Med 80:271-281, 2002
73. Fleckman P, Dale BA, Holbrook KA: Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol 85:507-512, 1985
74. Fluhr JW, Behne MJ, Brown BE, et al: Stratum corneum acidification in neonatal skin: Secretory phospholipase A2 and the sodium/hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol 122:320-329, 2004
75. Fluhr JW, Kao J, Jain M, Ahn SK, Feingold KR, Elias PM: Generation of free fatty acids from phospholipids regulates stratum corneum acidification and integrity. J Invest Dermatol 117:44-51, 2001
76. Fluhr JW, Mao-Qiang M, Brown BE, et al: Glycerol regulates stratum corneum hydration in sebaceous gland deficient (asebia) mice. J Invest Dermatol 120:728-737, 2003
77. Fowler AJ, Sheu MY, Schmuth M, et al: Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: Liver-X-receptor-specific inhibition of inflammation and primary cytokine production. J Invest Dermatol 120:246-255, 2003
78. Freinkel RK, Traczyk TN: Acid hydrolases of the epidermis: Subcellular localization and relationship to cornification. J Invest Dermatol 80:441-446, 1983
79. Fuchs E: Intermediate filaments and disease: Mutations that cripple cell strength. J Cell Biol 125:511-516, 1994
80. Fuchs E, Weber K: Intermediate filaments: Structure, dynamics, function, and disease. Annu Rev Biochem 63:345-382, 1994
81. Gallo RL, Nizet V: Endogenous production of antimicrobial peptides in innate immunity and human disease. Curr Allergy Asthma Rep 3:402-409, 2003
82. Ganz T: Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710-720, 2003
83. Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, Elias PM: Psychological stress perturbs epidermal permeability barrier homeostasis: Implications for the pathogenesis of stress-associated skin disorders. Arch Dermatol 137:53-59, 2001
84. Ghadially R, Brown BE, Hanley K, Reed JT, Feingold KR, Elias PM: Decreased epidermal lipid synthesis accounts for altered barrier function in aged mice. J Invest Dermatol 106:1064-1069, 1996a
85. Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM: The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 95:2281-2290, 1995
86. Ghadially R, Halkier-Sorensen L, Elias PM: Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 26:387-396, 1992a
87. Ghadially R, Reed JT, Elias PM: Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 107:558-564, 1996b
88. Ghadially R, Williams ML, Hou SY, Elias PM: Membrane structural abnormalities in the stratum corneum of the autosomal recessive ichthyoses. J Invest Dermatol 99:755-763, 1992b
89. Giusti F, Martella A, Bertoni L, Seidenari S: Skin barrier, hydration, and pH of the skin of infants under 2 years of age. Pediatr Dermatol 18:93-96, 2001
90. Gläser R, Harder J, Lange H, Bartels J, Christophers E, Schröder JM: Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection. Nat Immunol 6:57-64, 2005
91. Grayson S, Johnson-Winegar AG, Wintroub BU, Isseroff RR, Epstein EH Jr, Elias PM: Lamellar body-enriched fractions from neonatal mice: Preparative techniques and partial characterization. J Invest Dermatol 85:289-294, 1985
92. Grubauer G, Elias PM, Feingold KR: Transepidermal water loss: The signal for recovery of barrier structure and function. J Lipid Res 30:323-333, 1989
93. Grubauer G, Feingold KR, Elias PM: Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 28:746-752, 1987
94. Hachem JP, Crumrine D, Fluhr J, Brown BE, Feingold KR, Elias PM: pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121:345-353, 2003
95. Haftek M, Cambazard F, Dhouailly D, et al: A longitudinal study of a harlequin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol 135:448-453, 1996
96. Hanley K, Feingold KR, Komuves LG, Elias PM, Muglia LJ, Majzoub JA, Williams ML: Glucocorticoid deficiency delays stratum corneum maturation in the fetal mouse. J Invest Dermatol 111:440-444, 1998
97. Hanley K, Jiang Y, Crumrine D, et al: Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier. J Clin Invest 100:705-712, 1997
98. Hanley K, Komuves LG, Bass NM, et al: Fetal epidermal differentiation and barrier development in vivo is accelerated by nuclear hormone receptor activators. J Invest Dermatol 113:788-795, 1999
99. Hanley K, Komuves LG, Ng DC, et al: Farnesol stimulates differentiation in epidermal keratinocytes via PPARalpha. J Biol Chem 275:11484-11491, 2000a
100. Hanley K, Ng DC, He SS, et al: Oxysterols induce differentiation in human keratinocytes and increase Ap-1-dependent involucrin transcription. J Invest Dermatol 114:545-553, 2000b
101. Hanley K, Rassner U, Elias PM, Williams ML, Feingold KR: Epidermal barrier ontogenesis: Maturation in serum-free media and acceleration by glucocorticoids and thyroid hormone but not selected growth factors. J Invest Dermatol 106:404-411, 1996a
102. Hanley K, Rassner U, Jiang Y, et al: Hormonal basis for the gender difference in epidermal barrier formation in the fetal rat. Acceleration by estrogen and delay by testosterone. J Clin Invest 97:2576-2584, 1996b
103. Hanson KM, Behne MJ, Barry NP, Mauro TM, Gratton E, Clegg RM: Two-photon fluorescence lifetime imaging of the skin stratum corneum pH gradient. Biophys J 83:1682-1690, 2002
104. Hansson L, Stromqvist M, Backman A, Wallbrandt P, Carlstein A, Egelrud T: Cloning, expression, and characterization of stratum corneum chymotryptic enzyme. A skin-specific human serine proteinase. J Biol Chem 269:19420-19426, 1994
105. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115:406-413, 2000
106. Harder J, Schröder JM: RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 277:46779-46784, 2002
107. Harder J, Schröder JM: Psoriatic scales: A promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol 77:476-486, 2005
108. Harding CR, Watkinson A, Rawlings AV, Scott IR: Dry skin, moisturization, and corneodesmolysis. Inter J Cosm Sci 22:21-52, 2000
109. Harris IR, Farrell AM, Grunfeld C, Holleran WM, Elias PM, Feingold KR: Permeability barrier disruption coordinately regulates mRNA levels for key enzymes of cholesterol, fatty acid, and ceramide synthesis in the epidermis. J Invest Dermatol 109:783-787, 1997
110. Harris IR, Farrell AM, Holleran WM, Jackson S, Grunfeld C, Elias PM, Feingold KR: Parallel regulation of sterol regulatory element binding protein-2 and the enzymes of cholesterol and fatty acid synthesis but not ceramide synthesis in cultured human keratinocytes and murine epidermis. J Lipid Res 39:412-422, 1998
111. Hennings H, Steinert P, Buxman MM: Calcium induction of transglutaminase and the formation of epsilon (gamma-glutamyl) lysine cross-links in cultured mouse epidermal cells. Biochem Biophys Res Commun 102:739-745, 1981
112. Hohl D: Cornified cell envelope. Dermatologica 180:201-211, 1990
113. Hohl D, Huber M, Frenk E: Analysis of the cornified cell envelope in lamellar ichthyosis. Arch Dermatol 129:618-624, 1993
114. Hohl D, Mehrel T, Lichti U, Turner ML, Roop DR, Steinert PM: Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins. J Biol Chem 266:6626-6636, 1991
115. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991a
116. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 88:1338-1345, 1991b
117. Horikoshi T, Arany I, Rajaraman S, et al: Isoforms of cathepsin D and human epidermal differentiation. Biochimie 80:605-612, 1998
118. Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM: Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation. Br J Dermatol 141:453-459, 1999
119. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY: Selective killing of vaccinia virus by LL-37: Implications for eczema vaccinatum. J Immunol 172:1763-1767, 2004
120. Huber M, Rettler I, Bernasconi K, et al: Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267:525-528, 1995
121. Huh WK, Oono T, Shirafuji Y, et al: Dynamic alteration of human beta-defensin 2 localization from cytoplasm to intercellular space in psoriatic skin. J Mol Med 80:678-684, 2002
122. Hurt CM, Hanley K, Williams ML, Feingold KR: Cutaneous lipid synthesis during late fetal development in the rat. Arch Dermatol Res 287:754-760, 1995
123. Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526, 1991
124. Ishida-Yamamoto A, Iizuka H: Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp Dermatol 7:1-10, 1998
125. Jensen JM, Schutze S, Forl M, Kronke M, Proksch E: Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 104:1761-1770, 1999
126. Jonca N, Guerrin M, Hadjiolova K, Caubet C, Gallinaro H, Simon M, Serre G: Corneodesmosin, a component of epidermal corneocyte desmosomes, displays homophilic adhesive properties. J Biol Chem 277:5024-5029, 2002
127. Kalinin AE, Kajava AV, Steinert PM: Epithelial barrier function: Assembly and structural features of the cornified cell envelope. Bioessays 24:789-800, 2002
128. Kao JS, Fluhr JW, Man MQ, et al: Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: Inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 120:456-464, 2003
129. Kao JS, Garg A, Mao-Qiang M, Crumrine D, Ghadially R, Feingold KR, Elias PM: Testosterone perturbs epidermal permeability barrier homeostasis. J Invest Dermatol 116:443-451, 2001
130. Kimonis V, DiGiovanna JJ, Yang JM, Doyle SZ, Bale SJ, Compton JG: A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol 103:764-769, 1994
131. Komatsu N, Takata M, Otsuki N, Ohka R, Amano O, Takehara K, Saijoh K: Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides. J Invest Dermatol 118:436-443, 2002
132. Komuves LG, Hanley K, Jiang Y, Elias PM, Williams ML, Feingold KR: Ligands and activators of nuclear hormone receptors regulate epidermal differentiation during fetal rat skin development. J Invest Dermatol 111: 429-433, 1998
133. Komuves LG, Hanley K, Man MQ, Elias PM, Williams ML, Feingold KR: Keratinocyte differentiation in hyperproliferative epidermis: Topical application of PPARalpha activators restores tissue homeostasis. J Invest Dermatol 115:361-367, 2000
134. Korting HC, Hubner K, Greiner K, Hamm G, Braun-Falco O: Differences in the skin surface pH and bacterial microflora due to the long-term application of synthetic detergent preparations of pH 5.5 and pH 7.0. Results of a crossover trial in healthy volunteers. Acta Derm Venereol 70:429-431, 1990
135. Kreder D, Krut O, Adam-Klages S, et al: Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J 18:2472-2479, 1999
136. Krien P, Kermici M: Evidence for the existence of a self-regulated enzymatic process within human stratum corneum-an unexpected role for urocanic acid. J Invest Dermatol 115:414-420, 2000
137. Kupper TS: Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. J Clin Invest 86:1783-1789, 1990
138. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM: Human stratum corneum lipids: Characterization and regional variations. J Lipid Res 24:120-130, 1983
139. Landmann L: The epidermal permeability barrier. Anat Embryol (Berl) 178:1-13, 1988
140. Lavrijsen AP, Bouwstra JA, Gooris GS, Weerheim A, Bodde HE, Ponec M: Reduced skin barrier function parallels abnormal stratum corneum lipid organization in patients with lamellar ichthyosis. J Invest Dermatol 105: 619-624, 1995
141. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Quiang M, Feingold KR: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-538, 1992
142. Leyden JJ, Stewart R, Kligman AM: Updated in vivo methods for evaluating topical antimicrobial agents on human skin. J Invest Dermatol 72: 165-170, 1979
143. Liou A, Elias PM, Grunfeld C, Feingold KR, Wood LC: Amphiregulin and nerve growth factor expression are regulated by barrier status in murine epidermis. J Invest Dermatol 108:73-77, 1997
144. Liu AY, Destoumieux D, Wong AV, Park CH, Valore EV, Liu L, Ganz T: Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol 118:275-281, 2002
145. Loewen CJ, Levine TP: Cholesterol homeostasis: Not until the SCAP lady INSIGs. Curr Biol 12:R779-R781, 2002
146. Lundstrom A, Serre G, Haftek M, Egelrud T: Evidence for a role of corneodesmosin, a protein which may serve to modify desmosomes during cornification, in stratum corneum cell cohesion and desquamation. Arch Dermatol Res 286:369-375, 1994
147. Madison KC, Sando GN, Howard EJ, True CA, Gilbert D, Swartzendruber DC, Wertz PW: Lamellar granule biogenesis: A role for ceramide glucosyltransferase, lysosomal enzyme transport, and the Golgi. J Invest Dermatol Symp Proc 3:80-86, 1998
148. Maestrini E, Monaco AP, McGrath JA, et al: A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 13:70-77, 1996
149. Man MM, Feingold KR, Thornfeldt CR, Elias PM: Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol 106:1096-1101, 1996
150. Man MQ, Feingold KR, Elias PM: Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin. Arch Dermatol 129:728-738, 1993
151. Mao-Qiang M, Brown BE, Wu-Pong S, Feingold KR, Elias PM: Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 131:809-816, 1995a
152. Mao-Qiang M, Elias PM, Feingold KR: Fatty acids are required for epidermal permeability barrier function. J Clin Invest 92:791-798, 1993a
153. Mao-Qiang M, Feingold KR, Jain M, Elias PM: Extracellular processing of phospholipids is required for permeability barrier homeostasis. J Lipid Res 36:1925-1935, 1995b
154. Mao-Qiang M, Jain M, Feingold KR, Elias PM: Secretory phospholipase A2 activity is required for permeability barrier homeostasis. J Invest Dermatol 106:57-63, 1996
155. Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273: 17763-17770, 1998
156. Mauro T, Holleran WM, Grayson S, et al: Barrier recovery is impeded at neutral pH, independent of ionic effects: Implications for extracellular lipid processing. Arch Dermatol Res 290:215-222, 1998
157. Maury E, Prevost MC, Simon MF, et al: Identification of two secreted phospholipases A2 in human epidermis. J Invest Dermatol 114:960-966, 2000
158. Mazereeuw-Hautier J, Redoules D, Tarroux R, et al: Identification of pancreatic type I secreted phospholipase A2 in human epidermis and its determination by tape stripping. Br J Dermatol 142:424-431, 2000
159. Menon GK, Elias PM: Morphologic basis for a pore-pathway in mammalian stratum corneum. Skin Pharmacol 10:235-246, 1997
160. Menon GK, Elias PM, Feingold KR: Integrity of the permeability barrier is crucial for maintenance of the epidermal calcium gradient. Br J Dermatol 130: 139-147, 1994a
161. Menon GK, Feingold KR, Elias PM: Lamellar body secretory response to barrier disruption. J Invest Dermatol 98:279-289, 1992
162. Menon GK, Feingold KR, Moser AH, Brown BE, Elias PM: De novo sterologenesis in the skin. II. Regulation by cutaneous barrier requirements. J Lipid Res 26:418-427, 1985a
163. Menon GK, Grayson S, Elias PM: Ionic calcium reservoirs in mammalian epidermis: Ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 84:508-512, 1985b
164. Menon GK, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 102:789-795, 1994b
165. Menton DN, Eisen AZ: Structure and organization of mammalian stratum corneum. J Ultrastruct Res 35:247-264, 1971
166. Miller SJ, Aly R, Shinefeld HR, Elias PM: In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 124:209-215, 1988
167. Molhuizen HO, Alkemade HA, Zeeuwen PL, de Jongh GJ, Wieringa B, Schalkwijk J: SKALP/elafin: An elastase inhibitor from cultured human keratinocytes. Purification, cDNA sequence, and evidence for transglutaminase crosslinking. J Biol Chem 268:12028-12032, 1993
168. Moskowitz DG, Fowler AJ, Heyman MB, Cohen SP, Crumrine D, Elias PM, Williams ML: Pathophysiological basis for growth failure in children with ichthyosis: An evaluation of cutaneous ultrastructure, epidermal permeability barrier function, and energy expenditure. J Pediatr, in press
169. Narce M, Poisson JP: Lipid metabolism: Regulation of lipid metabolism gene expression by peroxisome proliferator-activated receptor alpha and sterol regulatory element binding proteins. Curr Opin Lipidol 13:445-447, 2002
170. Nickoloff BJ, Naidu Y: Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 30:535-546, 1994
171. Nizet V, Ohtake T, Lauth X, et al: Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414:454-457, 2001
172. Noonan FP, De Fabo EC: Immunosuppression by ultraviolet B radiation: Initiation by urocanic acid. Immunol Today 13:250-254, 1992
173. Norlen L: Skin barrier formation: The membrane folding model. J Invest Dermatol 117:823-829, 2001a
174. Norlen L: Skin barrier structure and function: The single gel phase model. J Invest Dermatol 117:830-836, 2001b
175. Odland GF, Holbrook K: The lamellar granules of epidermis. Curr Probl Dermatol 9:29-49, 1981
176. Ohman H, Vahlquist A: In vivo studies concerning a pH gradient in human stratum corneum and upper epidermis. Acta Derm Venereol 74:375-379, 1994
177. Ong PY, Ohtake T, Brandt C, et al: Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151-1160, 2002
178. Oren A, Ganz T, Liu L, Meerloo T: In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 74:180-182, 2003
179. Orlowski J, Grinstein S: Na+/H+ exchangers of mammalian cells. J Biol Chem 272:22373-22376, 1997
180. Ottey KA, Wood LC, Grunfeld C, Elias PM, Feingold KR: Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J Invest Dermatol 104:401-404, 1995
181. Potts RO, Francoeur ML: Lipid biophysics of water loss through the skin. Proc Natl Acad Sci USA 87:3871-3873, 1990
182. Proksch E, Elias PM, Feingold KR: Regulation of 3-hydroxy-3- methylglutaryl-coenzyme A reductase activity in murine epidermis. Modulation of enzyme content and activation state by barrier requirements. J Clin Invest 85:874-882, 1990
183. Proksch E, Jensen JM, Elias PM: Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 21:134-144, 2003
184. Rawson RB: The SREBP pathway-insights from Insigs and insects. Nat Rev Mol Cell Biol 4:631-640, 2003
185. Redoules D, Tarroux R, Assalit MF, Peri JJ: Characterisation and assay of five enzymatic activities in the stratum corneum using tape-strippings. Skin Pharmacol Appl Skin Physiol 12:182-192, 1999
186. 2+ in the second stage. J Biol Chem 268:25139-25145, 1993
187. Risse BC, Brown H, Lavker RM, Pearson JM, Baker MS, Ginsburg D, Jensen PJ: Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2). Histochem Cell Biol 110:559-569, 1998
188. Risse BC, Chung NM, Baker MS, Jensen PJ: Evidence for intracellular cleavage of plasminogen activator inhibitor type 2 (PAI-2) in normal epidermal keratinocytes. J Cell Physiol 182:281-289, 2000
189. Rivier M, Castiel I, Safonova I, Ailhaud G, Michel S: Peroxisome proliferator-activated receptor-alpha enhances lipid metabolism in a skin equivalent model. J Invest Dermatol 114:681-687, 2000
190. Rothnagel JA, Dominey AM, Dempsey LD, et al: Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science 257:1128-1130, 1992
191. Ruhl R, Dahten A, Schweigert FJ, Herz U, Worm M: Inhibition of IgE-production by peroxisome proliferator-activated receptor ligands. J Invest Dermatol 121:757-764, 2003
192. Sarangarajan R, Shumaker H, Soleimani M, Le Poole C, Boissy RE: Molecular and functional characterization of sodium-hydrogen exchanger in skin as well as cultured keratinocytes and melanocytes. Biochim Biophys Acta 1511:181-192, 2001
193. Sato J, Denda M, Chang S, Elias PM, Feingold KR: Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol 119:900-904, 2002
194. Schadow A, Scholz-Pedretti K, Lambeau G, Gelb MH, Furstenberger G, Pfeilschifter J, Kaszkin M: Characterization of group X phospholipase A(2) as the major enzyme secreted by human keratinocytes and its regulation by the phorbol ester TPA. J Invest Dermatol 116:31-39, 2001
195. Scheuplein RJ, Blank IH: Permeability of the skin. Physiol Rev 51:702-747, 1971
196. Schmuth M, Elias PM, Hanley K, et al: The effect of LXR activators on AP-1 proteins in keratinocytes. J Invest Dermatol 123:41-48, 2004a
197. Schmuth M, Fluhr JW, Crumrine DC, et al: Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 122:909-922, 2004b
198. Schmuth M, Haqq CM, Cairns WJ, et al: Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. J Invest Dermatol 122:971-983, 2004c
199. Schmuth M, Yosipovitch G, Williams ML, et al: Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis. J Invest Dermatol 117:837-847, 2001b
200. Schurer NY, Elias PM: The biochemistry and function of stratum corneum lipids. Adv Lipid Res 24:27-56, 1991
201. Scott IR: Factors controlling the expressed activity of histidine ammonia-lyase in the epidermis and the resulting accumulation of urocanic acid. Biochem J 194:829-838, 1981
202. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115:84-92, 1986
203. Serre G, Mils V, Haftek M, et al: Identification of late differentiation antigens of human cornified epithelia, expressed in re-organized desmosomes and bound to cross-linked envelope. J Invest Dermatol 97:1061-1072, 1991
204. Sheu MY, Fowler AJ, Kao J, et al: Topical peroxisome proliferator activated receptor-alpha activators reduce inflammation in irritant and allergic contact dermatitis models. J Invest Dermatol 118:94-101, 2002
205. Simon M, Jonca N, Guerrin M, et al: Refined characterization of corneodesmosin proteolysis during terminal differentiation of human epidermis and its relationship to desquamation. J Biol Chem 276:20292-20299, 2001
206. Simon M, Montezin M, Guerrin M, Durieux JJ, Serre G: Characterization and purification of human corneodesmosin, an epidermal basic glycoprotein associated with corneocyte-specific modified desmosomes. J Biol Chem 272:31770-31776, 1997
207. Smith JR, Osborne TF, Brown MS, Goldstein JL, Gil G: Multiple sterol regulatory elements in promoter for hamster 3-hydroxy-3-methylglutaryl-coenzyme A synthase. J Biol Chem 263:18480-18487, 1988
208. Sondell B, Thornell LE, Stigbrand T, Egelrud T: Immunolocalization of stratum corneum chymotryptic enzyme in human skin and oral epithelium with monoclonal antibodies: Evidence of a proteinase specifically expressed in keratinizing squamous epithelia. J Histochem Cytochem 42:459-465, 1994
209. Sparavigna A, Setaro M, Gualandri V: Cutaneous pH in children affected by atopic dermatitis and in healthy children: A multicenter study. Skin Res Technol 5:221-227, 1999
210. Steinert PM, Marekov LN: Direct evidence that involucrin is a major early isopeptide cross-linked component of the keratinocyte cornified envelope. J Biol Chem 17:2021-2030, 1997
211. Sugarman JL, Fluhr JW, Fowler AJ, Bruckner T, Diepgen TL, Williams ML: The objective severity assessment of atopic dermatitis score: An objective measure using permeability barrier function and stratum corneum hydration with computer-assisted estimates for extent of disease. Arch Dermatol 139:1417-1422, 2003
212. Suzuki Y, Koyama J, Moro O, Horii I, Kikuchi K, Tanida M, Tagami H: The role of two endogenous proteases of the stratum corneum in degradation of desmoglein-1 and their reduced activity in the skin of ichthyotic patients. Br J Dermatol 134:460-464, 1996
213. Suzuki Y, Nomura J, Hori J, Koyama J, Takahashi M, Horii I: Detection and characterization of endogenous protease associated with desquamation of stratum corneum. Arch Dermatol Res 285:372-377, 1993
214. Swartzendruber DC, Wertz PW, Madison KC, Downing DT: Evidence that the corneocyte has a chemically bound lipid envelope. J Invest Dermatol 88:709-713, 1987
215. Takahashi M, Tezuka T, Katunuma N: Filaggrin linker segment peptide and cystatin alpha are parts of a complex of the cornified envelope of epidermis. Arch Biochem Biophys 329:123-126, 1996
216. Thompson RC, Ohlsson K: Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83:6692-6696, 1986
217. Thune P, Nilsen T, Hanstad IK, Gustavsen T, Lovig Dahl H: The water barrier function of the skin in relation to the water content of stratum corneum, pH and skin lipids. The effect of alkaline soap and syndet on dry skin in elderly, non-atopic patients. Acta Derm Venereol 68:277-283, 1988
218. Traupe H: Ichthyosis. A Guide to Clinical Diagnosis, Genetic Counseling, and Therapy. Berlin: Springer, 1989
219. Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071-2082, 2000
220. Vallett SM, Sanchez HB, Rosenfeld JM, Osborne TF: A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methyl- glutaryl coenzyme A reductase gene. J Biol Chem 271:12247-12253, 1996
221. van Hooijdonk CA, Colbers RM, Piek J, van Erp PE: Demonstration of an Na+/H+ exchanger in mouse keratinocytes measured by the novel pH-sensitive fluorochrome SNARF-calcein. Cell Prolif 30:351-363, 1997
222. Visscher MO, Chatterjee R, Munson KA, Pickens WL, Hoath SB: Changes in diapered and nondiapered infant skin over the first month of life. Pediatr Dermatol 17:45-51, 2000
223. Watkinson A, Harding C, Moore A, Coan P: Water modulation of stratum corneum chymotryptic enzyme activity and desquamation. Arch Dermatol Res 293:470-476, 2001
224. Wertz PW, Downing DT, Freinkel RK, Traczyk TN: Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. J Invest Dermatol 83:193-195, 1984
225. Wertz PW, Swartzendruber DC, Kitko DJ, Madison KC, Downing DT: The role of the corneocyte lipid envelope in cohesion of the stratum corneum. J Invest Dermatol 93:169-172, 1989
226. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E: Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 256:14791-14795, 1990
227. Wiedow O, Young JA, Davison MD, Christophers E: Antileukoprotease in psoriatic scales. J Invest Dermatol 101:305-309, 1993
228. Williams ML, Elias PM: From basket weave to barrier. Unifying concepts for the pathogenesis of the disorders of cornification. Arch Dermatol 129: 626-629, 1993
229. Williams ML, Elias PM: Enlightened therapy of the disorders of cornification. Clin Dermatol 21:269-273, 2003
230. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1 alpha expression and release from a preformed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
231. Wood LC, Elias PM, Sequeira-Martin SM, Grunfeld C, Feingold KR: Occlusion lowers cytokine mRNA levels in essential fatty acid-deficient and normal mouse epidermis, but not after acute barrier disruption. J Invest Dermatol 103:834-838, 1994a
232. Wood LC, Feingold KR, Sequeira-Martin SM, Elias PM, Grunfeld C: Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 3:56-60, 1994b
233. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992
234. Wood LC, Stalder AK, Liou A, Campbell IL, Grunfeld C, Elias PM, Feingold KR: Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol 6:98-104, 1997
235. Ye J, Garg A, Calhoun C, Feingold KR, Elias PM, Ghadially R: Alterations in cytokine regulation in aged epidermis: Implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol 11:209-216, 2002
236. Yosipovitch G, Tur E, Cohen O, Rusecki Y: Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care 16:560-563, 1993
237. Zaiou M, Gallo RL: Cathelicidins, essential gene-encoded mammalian antibiotics. J Mol Med 80:549-561, 2002
238. Zaiou M, Nizet V, Gallo RL: Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120:810-816, 2003
239. Zeeuwen PL, Dale BA, de Jongh GJ, et al: The human cystatin M/E gene (CST6): Exclusion candidate gene for harlequin ichthyosis. J Invest Dermatol 121:65-68, 2003
240. Zeeuwen PL, Van Vlijmen-Willems IM, Jansen BJ, et al: Cystatin M/E expression is restricted to differentiated epidermal keratinocytes and sweat glands: A new skin-specific proteinase inhibitor that is a target for cross-linking by transglutaminase. J Invest Dermatol 116:693-701, 2001
241. Zettersten E, Man MQ, Sato J, et al: Recessive x-linked ichthyosis: Role of cholesterol-sulfate accumulation in the barrier abnormality. J Invest Dermatol 111:784-790, 1998
242. Zettersten EM, Ghadially R, Feingold KR, Crumrine D, Elias PM: Optimal ratios of topical stratum corneum lipids improve barrier recovery in chronologically aged skin. J Am Acad Dermatol 37:403-408, 1997